PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson’s diseaseNeurodegeneration in Parkinson’s disease occurs via PAAN/MIF nuclease activity and is amenable to inhibition with a brain-penetrant small molecule inhibitor.Neurodegeneration in Parkinson’s disease occurs via PAAN/MIF nuclease activity and is amenable to inhibition with a brain-penetrant small molecule inhibitor.Hyejin Park, Tae-In Kam, Hanjing Peng, Shih-Ching Chou, Amir A. Mehrabani-Tabari, Jae-Jin Song, Xiling Yin, Senthilkumar S. Karuppagounder, George K. Umanah, A.V. Subba Rao, YuRee Choi, Akanksha Aggarwal, Sohyun Chang, Hyunhee Kim, Jiyoung Byun, Jun O. Liu, Ted M. Dawson, Valina L. Dawsonhttps://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900467-6%3Frss%3Dyes&rc=0http://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignMay 11, 2022

Powered by WPeMatico